<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="alzheimer-early" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">alzheimer-early</book-part-id>
      <title-group>
        <title>Early-Onset Familial Alzheimer Disease</title>
        <alt-title alt-title-type="alt-title">Synonym: EOFAD</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Bird</surname>
            <given-names>Thomas D</given-names>
          </name>
          <xref ref-type="aff" rid="alzheimer-early.AFF1"/>
          <degrees>MD</degrees>
          <email>tomnroz@u.washington.edu</email>
        </contrib>
      </contrib-group>
      <aff id="alzheimer-early.AFF1">Seattle VA Medical Center<break/>Departments of Neurology and Medicine<break/>University of Washington<break/>Seattle, Washington</aff>
      <pub-history>
        <date iso-8601-date="1999-09-24" date-type="created">
          <day>24</day>
          <month>09</month>
          <year>1999</year>
        </date>
        <date iso-8601-date="2010-12-23" date-type="updated">
          <day>23</day>
          <month>12</month>
          <year>2010</year>
        </date>
        <date iso-8601-date="2012-10-18" date-type="revised">
          <day>18</day>
          <month>10</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="weaver" document-type="chapter">
<italic toggle="yes">EZH2</italic>-Related Overgrowth</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="eds" document-type="chapter">Ehlers-Danlos Syndrome, Classic Type</related-object>
      <abstract id="alzheimer-early.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Alzheimer disease (AD) is characterized by adult-onset progressive dementia associated with cerebral cortical atrophy, beta-amyloid plaque formation, and intraneuronal neurofibrillary tangles. AD typically begins with subtle memory failure that becomes more severe and is eventually incapacitating. Other common findings include confusion, poor judgment, language disturbance, agitation, withdrawal, hallucinations, seizures, Parkinsonian features, increased muscle tone, myoclonus, incontinence, and mutism. Familial AD (FAD) characterizes families that have more than one member with AD and usually implies multiple affected persons in more than one generation. Early-onset FAD (EOFAD) refers to families in which onset is consistently before age 60 to 65 years and often before age 55 years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>EOFAD is diagnosed in families with multiple affected individuals with mean age of onset before 65 years and/or with a documented disease-causing mutation in one of the genes known to be associated with EOFAD. The three clinically indistinguishable subtypes of EOFAD based on the underlying genetic mechanism are: Alzheimer disease type 1 (AD1), caused by mutation of <italic toggle="yes">APP</italic> (10%-15% of EOFAD); Alzheimer disease type 3 (AD3), caused by mutation of <italic toggle="yes">PSEN1</italic>, (30%-70% of EOFAD); and Alzheimer disease type 4 (AD4), caused by mutation of <italic toggle="yes">PSEN2</italic> (&#x0003c;5% of EOFAD). Kindreds with autosomal dominant EOFAD with no identifiable mutations in <italic toggle="yes">PSEN1</italic>, <italic toggle="yes">PSEN2</italic>, or <italic toggle="yes">APP</italic> have been described; thus, it is likely that mutations in additional genes are causative. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Supportive; symptoms of depression, aggression, sleep disturbance, seizures, and hallucinations are managed on an individual basis; affected individuals eventually require assisted living/nursing home care; agents that increase cholinergic activity, such as Aricept<sup>&#x000ae;</sup> (donepezil), Exelon<sup>&#x000ae;</sup> (rivastigmine), and Reminy<sup>&#x000ae;</sup> (galatamine), show modest but variable benefit; memantine, an NMDA receptor antagonist, is approved for use in AD; physical and occupational therapy help manage activities of daily living.</p>
          <p><italic toggle="yes">Surveillance</italic>: Monthly monitoring to identify and manage secondary complications.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Sudden changes in environment; over-sedation.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>EOFAD is inherited in an autosomal dominant manner. Most individuals with EOFAD had an affected parent; occasionally, neither parent is identified as having had the disease, but a second-degree relative (e.g., an uncle, aunt, and/or grandparent) has or had EOFAD. Each child of an individual with EOFAD has a 50% chance of inheriting the mutation and developing EOFAD. Prenatal testing for pregnancies at increased risk for is possible if the disease-causing mutation in the family is known; however, prenatal testing for adult-onset disorders is uncommon.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="alzheimer-early.Diagnosis">
        <title>Diagnosis</title>
        <sec id="alzheimer-early.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Alzheimer disease (AD) (see <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer Disease Overview</related-object>) is diagnosed in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Adult-onset slowly progressive dementia</p>
            </list-item>
            <list-item>
              <p>Absence of other causes of dementia</p>
            </list-item>
            <list-item>
              <p>Cerebral cortical atrophy by neuroimaging studies</p>
            </list-item>
            <list-item>
              <p>Beta-amyloid neuritic plaques and intraneuronal neurofibrillary tangles at post-mortem examination (see diagnostic criteria, National Institute on Aging Working Group [1998]).</p>
            </list-item>
          </list>
          <p>Early-onset familial Alzheimer disease (EOFAD) is diagnosed in families that have more than one member with AD (usually multiple affected persons in more than one generation) in which the age of onset is consistently before age 60 to 65 years and often before age 55 years.</p>
        </sec>
        <sec id="alzheimer-early.Molecular_Genetic_Testin">
          <title>Molecular Genetic Testing</title>
          <p><bold>Genes.</bold> Mutations in three genes are known to be associated with early-onset familial Alzheimer disease:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">PSEN1.</italic></bold> Mutations are associated with Alzheimer disease type 3 (AD3) [<xref ref-type="bibr" rid="alzheimer-early.REF.larner.2006.139">Larner &#x00026; Doran 2006</xref>], which accounts for 30%-70% of EOFAD [<xref ref-type="bibr" rid="alzheimer-early.REF.cruts.1998.183">Cruts &#x00026; Van Broeckhoven 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.campion.1999.664">Campion et al 1999</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.rogaeva.2001.621">Rogaeva et al 2001</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.lleo.2002.1759">Lle&#x000f3; et al 2002</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.janssen.2003.235">Janssen et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">APP.</italic></bold> Mutations are associated with Alzheimer disease type 1 (AD1) [<xref ref-type="bibr" rid="alzheimer-early.REF.vanbroeckhove.1995.8">Van Broeckhoven 1995</xref>], which accounts for no more than 10%-15% of EOFAD [<xref ref-type="bibr" rid="alzheimer-early.REF.campion.1999.664">Campion et al 1999</xref>]. </p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">PSEN2.</italic></bold> Mutations are associated with Alzheimer disease type 4 (AD4), which accounts for less than 5% of all EOFAD. AD4 has been identified in a few families (most are of Volga German ancestry) living in the United States, in three Italian kindreds [<xref ref-type="bibr" rid="alzheimer-early.REF.bird.1988.25">Bird et al 1988</xref>], in two Italian kindreds [<xref ref-type="bibr" rid="alzheimer-early.REF.finckh.2000.2006">Finckh et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.marcon.2004.199">Marcon et al 2004</xref>], and in two Spanish families [<xref ref-type="bibr" rid="alzheimer-early.REF.beyer.1998.587">Beyer et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.lleo.2001.1926">Lle&#x000f3; et al 2001</xref>].</p>
            </list-item>
          </list>
          <p><bold>Other loci.</bold> Kindreds with autosomal dominant EOFAD who have no identifiable mutations in <italic toggle="yes">PSEN1</italic>, <italic toggle="yes">PSEN2</italic>, or <italic toggle="yes">APP</italic> have been described; thus, it is likely that mutations in additional genes are causative [<xref ref-type="bibr" rid="alzheimer-early.REF.cruts.1998.43">Cruts et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.janssen.2003.235">Janssen et al 2003</xref>].</p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <p>
            <bold>
              <italic toggle="yes">PSEN1</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Targeted mutation analysis.</bold> A 4555-bp deletion spanning exon 9 is found in the Finnish population [<xref ref-type="bibr" rid="alzheimer-early.REF.crook.1998.452">Crook et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.prihar.1999.1090">Prihar et al 1999</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.verkkoniem.2000.1103">Verkkoniemi et al 2000</xref>]; this mutation is rarely observed in other populations.</p>
            </list-item>
            <list-item>
              <p><bold>Sequence analysis</bold> of the coding region and associated intronic regions detects missense mutations known to result in EOFAD. This method also detects splice site mutations that result in transcripts lacking exon 9 [<xref ref-type="bibr" rid="alzheimer-early.REF.pereztur.1995.297">Perez-Tur et al 1995</xref>]. </p>
            </list-item>
            <list-item>
              <p><bold>Deletion/duplication analysis</bold> for screening the entire gene to detect rare exonic or whole-gene deletions [<xref ref-type="bibr" rid="alzheimer-early.REF.smith.2001.125">Smith et al 2001</xref>]. This testing can also detect the 4555-bp deletion in the Finnish population.</p>
            </list-item>
          </list>
          <p>
            <bold>
              <italic toggle="yes">APP</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis/mutation scanning.</bold> All pathogenic mutations, except for rare duplications (see following bullet), are only known to occur in exons 16 and 17. Most mutations are missense or nonsense; one indel is reported (<xref ref-type="table" rid="alzheimer-early.T.selected_app_pathogeni">Table 2</xref>). Sequence analysis is often limited to these exons because they encode the proteolytically cleaved A-beta peptide (see <xref ref-type="sec" rid="alzheimer-early.Molecular_Genetics">Molecular Genetics</xref>, <bold><italic toggle="yes">APP</italic></bold>). For this reason, laboratories sequencing only exons 16 and 17 may be listed as sequencing select exons or as sequencing the entire coding region; contacting the laboratory directly is advised.</p>
            </list-item>
            <list-item>
              <p><bold>Deletion/duplication analysis</bold> (including FISH analysis). Duplication of <italic toggle="yes">APP</italic> represents fewer than 1% of <italic toggle="yes">APP</italic> pathogenic mutations [<xref ref-type="bibr" rid="alzheimer-early.REF.roveletlecru.2006.24">Rovelet-Lecrux et al 2006</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>
              <italic toggle="yes">PSEN2</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis</bold> of the coding region detects missense mutations known to cause EOFAD.</p>
            </list-item>
          </list>
          <table-wrap id="alzheimer-early.T.summary_of_molecular_g" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Early-Onset Familial Alzheimer Disease</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Proportion of EOFAD Attributed to Mutations in This Gene</th>
                  <th id="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Gene and Test Method&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_1" align="left" valign="middle" rowspan="3" colspan="1">
                    <italic toggle="yes">PSEN1</italic>
                  </td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_2" align="left" valign="middle" rowspan="3" colspan="1">30%-70%&#x000a0;<sup>4</sup>
</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Targeted mutation analysis</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">4555-bp deletion of exon 9 (Finnish founder mutation)&#x000a0;<sup>5</sup></td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">100% for the targeted mutation </td>
                </tr>
                <tr>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">~98%</td>
                </tr>
                <tr>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Partial- and whole-gene deletions, including exon 9 Finnish founder deletion</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">100% for deletions, which are rare</td>
                </tr>
                <tr>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">APP</italic>
                  </td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">10%-15%</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup> / mutation scanning&#x000a0;<sup>8</sup> of exons 16 and 17</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants in exons 16 and 17</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">99%</td>
                </tr>
                <tr>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Partial- and whole-gene duplications</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">100% for the targeted duplication</td>
                </tr>
                <tr>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <italic toggle="yes">PSEN2</italic>
                  </td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;5%</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_b_alzheimer-early.T.summary_of_molecular_g_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">~100%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="alzheimer-early.TF.1">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="alzheimer-early" object-id="alzheimer-early.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="alzheimer-early.TF.1.1">
                <label>2.</label>
                <p>See <xref ref-type="sec" rid="alzheimer-early.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="alzheimer-early.TF.1.2">
                <label>3.</label>
                <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
              </fn>
              <fn id="alzheimer-early.TF.1.3">
                <label>4.</label>
                <p>The highest yield for identification of a mutation in <italic toggle="yes">PSEN1</italic> is for persons with early-onset (age &#x0003c;60 years) AD who have another affected family member (especially a parent) with early-onset AD [<xref ref-type="bibr" rid="alzheimer-early.REF.rogaeva.2001.621">Rogaeva et al 2001</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.lleo.2002.1759">Lle&#x000f3; et al 2002</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.janssen.2003.235">Janssen et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.tedde.2003.1541">Tedde et al 2003</xref>].</p>
              </fn>
              <fn id="alzheimer-early.TF.1.4">
                <label>5.</label>
                <p>Finnish population, this mutation is rarely observed in other populations. </p>
              </fn>
              <fn id="alzheimer-early.TF.1.5">
                <label>6.</label>
                <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>. </p>
              </fn>
              <fn id="alzheimer-early.TF.1.6">
                <label>7.</label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment. </p>
              </fn>
              <fn id="alzheimer-early.TF.1.7">
                <label>8.</label>
                <p>Sequence analysis and mutation scanning can have similar mutation detection frequencies; however, mutation detection frequencies for mutation scanning may vary considerably among laboratories depending on the specific protocol used.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>In one affected individual, a <italic toggle="yes">PSEN1</italic> mutation was identified in peripheral lymphocyte DNA; however, her clinical presentation was distinct from that of her affected deceased mother whose diagnosis was based on post-mortem neuropathology. Follow up studies demonstrated that the mother had somatic mosaicism for the <italic toggle="yes">PSEN1</italic> mutation; using sequence analysis, the mutation was detected in cerebral cortex DNA but not in peripheral lymphocyte DNA [<xref ref-type="bibr" rid="alzheimer-early.REF.beck.2004.1219">Beck et al 2004</xref>].</p>
        </sec>
        <sec id="alzheimer-early.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirming/establishing the diagnosis in a proband</bold> requires molecular genetic testing to identify a disease-causing mutation in one of the three genes known to be associated with EOFAD.</p>
          <list list-type="bullet">
            <list-item>
              <p>When the family history is positive for early-onset AD:</p>
              <list list-type="bullet">
                <list-item>
                  <p>First perform sequence analysis of <italic toggle="yes">PSEN1</italic>, the gene most commonly associated with EOFAD. If the affected individual is of Finnish ancestry, targeted mutation analysis of <italic toggle="yes">PSEN1</italic> can be performed first.</p>
                </list-item>
                <list-item>
                  <p>If no mutation is identified, perform sequence analysis of exons 16 and 17 of <italic toggle="yes">APP</italic> and all of <italic toggle="yes">PSEN2</italic>.Note: Duplication analysis of <italic toggle="yes">APP</italic> and of <italic toggle="yes">PSEN1</italic> need only be done if the goal is to test for even the rarest mutations.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>In simplex cases (i.e., a single occurrence in a family) the testing strategy is similar, but the likelihood of finding a disease-causing mutation is relatively low (~6% in the study by <xref ref-type="bibr" rid="alzheimer-early.REF.lleo.2002.1759">Lle&#x000f3; et al [2002]</xref>). However, the likelihood of finding a mutation in a simplex case increases as age of onset decreases, especially in those with onset before age 50 years.</p>
            </list-item>
          </list>
          <p>Note: Mutation detection frequency is low in persons with late-onset AD regardless of family history. Ninety percent of persons with <italic toggle="yes">PSEN1</italic> mutations have onset before age 60 years.</p>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior identification of the disease-causing mutation in the family.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutation in the family.</p>
        </sec>
      </sec>
      <sec id="alzheimer-early.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="alzheimer-early.Natural_History">
          <title>Clinical Description</title>
          <p>Alzheimer disease (AD) typically begins with subtle and poorly recognized failure of memory [<xref ref-type="bibr" rid="alzheimer-early.REF.godbolt.2004.1743">Godbolt et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.ringman.2005.552">Ringman et al 2005</xref>]. Slowly, over a period of years, the memory loss becomes more severe and is eventually incapacitating. Other common symptoms include confusion, poor judgment, language disturbance, agitation, withdrawal, and hallucinations. Some individuals may develop seizures, Parkinsonian features, increased muscle tone, myoclonus, incontinence, and mutism [<xref ref-type="bibr" rid="alzheimer-early.REF.cummings.1998.S2">Cummings et al 1998</xref>]. Death usually results from general inanition, malnutrition, and pneumonia.</p>
          <p><bold>AD3 (<italic toggle="yes">PSEN1</italic> mutations).</bold> Age of onset is usually in the 40s or early 50s. Onset in the 30s and early 60s has been reported. Onset after age 65 years is thought to be rare. Relatively rapid progression over six to seven years is common and the disease is often associated with seizures, myoclonus, and language deficits [<xref ref-type="bibr" rid="alzheimer-early.REF.fox.1997.491">Fox et al 1997</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.gustafson.1998.253">Gustafson et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.menendez.2004.475">Men&#x000e9;ndez 2004</xref>]. Several families have had associated spastic paraplegia with "cotton wool" amyloid plaques [<xref ref-type="bibr" rid="alzheimer-early.REF.crook.1998.452">Crook et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.brooks.2003.783">Brooks et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.ataka.2004.1773">Ataka et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.hattori.2004.319">Hattori et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.raman.2007.78">Raman et al 2007</xref>].</p>
          <p>The APOE e4 allele may influence age of onset [<xref ref-type="bibr" rid="alzheimer-early.REF.wijsman.2005.14">Wijsman et al 2005</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer Disease Overview</related-object>).</p>
          <p>CSF A&#x003b2;42 levels have been reported to be low in presymptomatic persons with <italic toggle="yes">PSEN1</italic> mutations [<xref ref-type="bibr" rid="alzheimer-early.REF.moonis.2005.323">Moonis et al 2005</xref>].</p>
          <p>PET scans with Pittsburgh compound-B show early amyloid deposition in the striatum in persons with <italic toggle="yes">PSEN1</italic> mutations [<xref ref-type="bibr" rid="alzheimer-early.REF.klunk.2007.6174">Klunk et al 2007</xref>].</p>
          <p><bold>AD4 (<italic toggle="yes">PSEN2</italic> mutations).</bold> AD4 has a wider range of onset age than either AD1 or AD3. The onset ranges from age 40 to 75 years with a few instances of non-penetrance after age 80 years [<xref ref-type="bibr" rid="alzheimer-early.REF.bird.1996.932">Bird et al 1996</xref>]. Mean duration of disease is 11 years. <xref ref-type="bibr" rid="alzheimer-early.REF.jayadev.2010.1143">Jayadev et al [2010]</xref> have reviewed the clinical, pathologic, and genetic aspects of families with mutation of <italic toggle="yes">PSEN2</italic>.</p>
          <p>The APOE e4 allele influences age of onset (see <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer Disease Overview</related-object>) [<xref ref-type="bibr" rid="alzheimer-early.REF.wijsman.2005.14">Wijsman et al 2005</xref>].</p>
          <p><bold>AD1 (<italic toggle="yes">APP</italic> mutations).</bold> The dementia observed in families with <italic toggle="yes">APP</italic> mutations is typical of AD. Age of onset is usually in the 40s and 50s (occasionally 60s). A few individuals have neuronal Lewy body inclusions in addition to plaques and tangles [<xref ref-type="bibr" rid="alzheimer-early.REF.revesz.1997.121">Revesz et al 1997</xref>].</p>
          <p>Homozygosity for the APOE e4 allele may be associated with younger age of onset (see <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer Disease Overview</related-object>).</p>
          <p><bold>Biomarkers</bold>. <xref ref-type="bibr" rid="alzheimer-early.REF.bateman.2012.795">Bateman et al [2012]</xref> identified biomarker changes in individuals with a mutation in <italic toggle="yes">APP</italic>, <italic toggle="yes">PSEN1</italic>, or <italic toggle="yes">PSEN2</italic> ten to 20 years prior to the onset of symptoms including amyloid deposition on PET imaging, decreased CSF beta-amyloid and increased CSF tau.</p>
          <p><bold>Neuropathology.</bold> Mutation of <italic toggle="yes">PSEN1</italic> (AD1) or <italic toggle="yes">PSEN2</italic> (AD4) results in excessive brain deposition of amyloid-&#x003b2; [<xref ref-type="bibr" rid="alzheimer-early.REF.mann.1997.52">Mann et al 1997</xref>] associated with neurofibrillary tangles and amyloid angiopathy. Lewy body pathology is also common [<xref ref-type="bibr" rid="alzheimer-early.REF.leverenz.2006.370">Leverenz et al 2006</xref>]. A wide range in severity of AD pathology may be seen [<xref ref-type="bibr" rid="alzheimer-early.REF.maarouf.2008.20">Maarouf et al 2008</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.jayadev.2010.1143">Jayadev et al 2010</xref>].</p>
        </sec>
        <sec id="alzheimer-early.GenotypePhenotype_Correl">
          <title>Genotype-Phenotype Correlations</title>
          <p>
            <bold>
              <italic toggle="yes">PSEN1</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Mutations in transmembrane loops 2, 4, and 6 account for some differences in age of onset and duration between those with mutation of <italic toggle="yes">PSEN1</italic> and of <italic toggle="yes">PSEN2</italic> [<xref ref-type="bibr" rid="alzheimer-early.REF.lippa.2000.376">Lippa et al 2000</xref>].</p>
            </list-item>
            <list-item>
              <p>A frontotemporal type of dementia with personality and behavioral changes has been associated with the mutant <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Leu113Pro</xref> [<xref ref-type="bibr" rid="alzheimer-early.REF.raux.2000.1577">Raux et al 2000</xref>] and <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Val89Leu</xref> [<xref ref-type="bibr" rid="alzheimer-early.REF.queralt.2002.266">Queralt et al 2002</xref>] PSEN1 proteins.</p>
            </list-item>
            <list-item>
              <p>Psychiatric symptoms at onset have been described in families with the mutant <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Leu392Pro</xref> and <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Met139Val</xref> PSEN1 proteins [<xref ref-type="bibr" rid="alzheimer-early.REF.tedde.2000.1590">Tedde et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.rippon.2003.884">Rippon et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Deletion of exon 9 in <italic toggle="yes">PSEN1</italic> is associated with early spastic paraparesis [<xref ref-type="bibr" rid="alzheimer-early.REF.crook.1998.452">Crook et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.verkkoniem.2000.1103">Verkkoniemi et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.brooks.2003.783">Brooks et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="alzheimer-early.REF.gomezisla.1999.1709">G&#x000f3;mez-Isla et al [1999]</xref> have correlated the neuropathologic features of amyloid plaques and neurofibrillary tangle formation with various <italic toggle="yes">PSEN1</italic> mutations.</p>
            </list-item>
            <list-item>
              <p>Very early onset (mean age 30 years) with additional Lewy body pathology has been associated with the mutant <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Met233Val</xref> and <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Tyr256Ser</xref> PSEN1 proteins [<xref ref-type="bibr" rid="alzheimer-early.REF.miklossy.2003.655">Miklossy et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Two <italic toggle="yes">PSEN1</italic> mutations have been associated with pathologic changes of Pick's disease: <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">c.548G&#x0003e;T</xref> and <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">c.436A&#x0003e;C</xref> [<xref ref-type="bibr" rid="alzheimer-early.REF.dermaut.2004.617">Dermaut et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.halliday.2005.139">Halliday et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Later-onset FAD (50s-70s) has been associated with the mutant <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Ala79Val</xref> and <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Arg269His</xref> PSEN1 proteins [<xref ref-type="bibr" rid="alzheimer-early.REF.brickell.2007.1050">Brickell et al 2007</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.kauwe.2007.446">Kauwe et al 2007</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.larner.2007.173">Larner et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>Purkinje cell loss in the cerebellum has been reported with the <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Ser170Phe</xref> mutation in <italic toggle="yes">PSEN1</italic> [<xref ref-type="bibr" rid="alzheimer-early.REF.piccini.2007.738">Piccini et al 2007</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>
              <italic toggle="yes">APP</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The combination of cerebral hemorrhage and presenile dementia is caused by a <xref ref-type="table" rid="alzheimer-early.T.selected_app_pathogeni">p.Ala692Gly</xref> mutation in <italic toggle="yes">APP</italic> [<xref ref-type="bibr" rid="alzheimer-early.REF.roks.2000.2130">Roks et al 2000</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="alzheimer-early.REF.difede.2009.1473">Di Fede et al [2009]</xref> reported that the <xref ref-type="table" rid="alzheimer-early.T.selected_app_pathogeni">p.Ala673Val</xref> mutation in <italic toggle="yes">APP</italic> only causes disease in the homozygous state; therefore, inheritance is autosomal recessive. This mutation is at the site where BACE1 cleaves the APP protein, part of the process that produces the &#x003b2;-amyloid peptide. <xref ref-type="bibr" rid="alzheimer-early.REF.giaccone.2010.803">Giaccone et al [2010]</xref> reported neuropathologic findings in a member of this family that included severe, typical plaque and tangle deposits of AD as well as &#x003b2;-amyloid deposition in the cerebellum.</p>
            </list-item>
            <list-item>
              <p>The <xref ref-type="table" rid="alzheimer-early.T.selected_app_pathogeni">p.Glu693Gly</xref> mutation (the "Arctic" mutation) in <italic toggle="yes">APP</italic>, present in a Swedish family, is associated with enhanced &#x003b2; amyloid protofibril formation [<xref ref-type="bibr" rid="alzheimer-early.REF.nilsberth.2001.887">Nilsberth et al 2001</xref>] and marked congophilic angiopathy [<xref ref-type="bibr" rid="alzheimer-early.REF.basun.2008.499">Basun et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>EOFAD has been associated with <italic toggle="yes">APP</italic> locus duplication [<xref ref-type="bibr" rid="alzheimer-early.REF.roveletlecru.2006.24">Rovelet-Lecrux et al 2006</xref>]. Amyloid angiopathy [<xref ref-type="bibr" rid="alzheimer-early.REF.sleegers.2006.2977">Sleegers et al 2006</xref>] and Lewy body pathology [<xref ref-type="bibr" rid="alzheimer-early.REF.guyantmare.2008.1925">Guyant-Marechal et al 2008</xref>] have been noted in single families with an <italic toggle="yes">APP</italic> duplication.</p>
            </list-item>
          </list>
        </sec>
        <sec id="alzheimer-early.Penetrance">
          <title>Penetrance</title>
          <p><bold>AD3 (<italic toggle="yes">PSEN1</italic> mutations).</bold> Penetrance is complete by age 65 years, except for occasional later onset associated with the mutations <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Ala79Val</xref> and <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Arg269His</xref> [<xref ref-type="bibr" rid="alzheimer-early.REF.brickell.2007.1050">Brickell et al 2007</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.kauwe.2007.446">Kauwe et al 2007</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.larner.2007.173">Larner et al 2007</xref>].</p>
          <p><bold>AD4 (<italic toggle="yes">PSEN2</italic> mutations).</bold> Penetrance is approximately 95%. In rare instances, individuals with <italic toggle="yes">PSEN2</italic> mutations who are older than age 80 years have no manifestations of AD.</p>
        </sec>
        <sec id="alzheimer-early.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been documented.</p>
        </sec>
        <sec id="alzheimer-early.Prevalence">
          <title>Prevalence</title>
          <p><xref ref-type="bibr" rid="alzheimer-early.REF.campion.1999.664">Campion et al [1999]</xref> found a prevalence of early-onset AD of 41.2 per 100,000 for the population at risk (i.e., persons aged 40-59 years).</p>
          <list list-type="bullet">
            <list-item>
              <p>Sixty-one percent of individuals with early-onset AD had a positive family history and 13% had affected individuals in three generations [<xref ref-type="bibr" rid="alzheimer-early.REF.campion.1999.664">Campion et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p>EOFAD comprises less than 3% of all AD.</p>
            </list-item>
            <list-item>
              <p>Some families with Volga German ancestry have a founder mutation in <italic toggle="yes">PSEN2</italic> (<xref ref-type="table" rid="alzheimer-early.T.selected_psen2_pathoge">c.422A&#x0003e;T</xref>) that has been reported in modern Germany [<xref ref-type="bibr" rid="alzheimer-early.REF.nikisch.2008.579">Nikisch et al 2008</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.jayadev.2010.1143">Jayadev et al 2010</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.yu.2010.631">Yu et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Among families with EOFAD, 40%-80% have a mutation in <italic toggle="yes">APP</italic>, PSEN1, or <italic toggle="yes">PSEN2</italic> (<italic toggle="yes">PSEN1</italic> being the most common) [<xref ref-type="bibr" rid="alzheimer-early.REF.janssen.2003.235">Janssen et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.kowalska.2003.231">Kowalska et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.tedde.2003.1541">Tedde et al 2003</xref>]. The frequency of such mutations in simplex cases (i.e., a single occurrence in a family) of early-onset AD in the 50s is not well documented, but is apparently low (&#x0003c;5%); the frequency is higher in those with onset before age 50 years.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">APP</italic> duplication is quite rare, having been found in none of 141 persons with EOAD (75 familial) screened in Sweden and Finland [<xref ref-type="bibr" rid="alzheimer-early.REF.blom.2008.171">Blom et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">PSEN1</italic> mutations have been reported in Japanese [<xref ref-type="bibr" rid="alzheimer-early.REF.furuya.2003.75">Furuya et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.hattori.2004.319">Hattori et al 2004</xref>], African American [<xref ref-type="bibr" rid="alzheimer-early.REF.rippon.2003.884">Rippon et al 2003</xref>], and Black African [<xref ref-type="bibr" rid="alzheimer-early.REF.heckmann.2004.133">Heckmann et al 2004</xref>] families. The founder mutation <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Ala431Glu</xref> has been reported in Mexican families [<xref ref-type="bibr" rid="alzheimer-early.REF.yescas.2006.195">Yescas et al 2006</xref>], the founder mutation <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">p.Glu280Ala</xref> in Colombian families [<xref ref-type="bibr" rid="alzheimer-early.REF.pastor.2003.163">Pastor et al 2003</xref>], and the founder mutation <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">c.839A&#x0003e;C</xref> in Caribbean Hispanics [<xref ref-type="bibr" rid="alzheimer-early.REF.athan.2001.2257">Athan et al 2001</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="alzheimer-early.Genetically_Related_Alle">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">PSEN1</italic> and <italic toggle="yes">PSEN2</italic></bold>. One study has found mutation of <italic toggle="yes">PSEN1</italic> and <italic toggle="yes">PSEN2</italic> in families with dilated cardiomyopathy only [<xref ref-type="bibr" rid="alzheimer-early.REF.li.2006.1030">Li et al 2006</xref>].</p>
        <p><bold><italic toggle="yes">APP</italic></bold>. Another phenotype associated with mutation of <italic toggle="yes">APP</italic> is cerebral hemorrhagic amyloidosis of the Dutch type, a disorder in which dementia and brain amyloid plaques are uncommon. This disorder results from a <xref ref-type="table" rid="alzheimer-early.T.selected_app_pathogeni">p.Glu693Gly</xref> mutant protein.</p>
      </sec>
      <sec id="alzheimer-early.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Approximately 75% of individuals with Alzheimer disease (AD) have no family history of AD and approximately 25% of individuals with AD can be divided into several genetic subgroups. Familial cases appear to have the same phenotype as nonfamilial cases both clinically and pathologically and thus are distinguished only by a positive family history (see <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer Disease Overview</related-object>). Occasionally, cases of early-onset AD may occur in families with generally late-onset disease [<xref ref-type="bibr" rid="alzheimer-early.REF.brickell.2006.1307">Brickell et al 2006</xref>].</p>
        <p>Other genetic causes of early-onset dementia include forms of frontotemporal dementia (e.g., <related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter">frontotemporal dementia with parkinsonism-17</related-object> [FTDP-17], <related-object link-type="booklink" source-id="gene" document-id="ibmpfd" document-type="chapter">inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia</related-object> [IBMPFD], <related-object link-type="booklink" source-id="gene" document-id="ftd-grn" document-type="chapter"><italic toggle="yes">PGRN</italic>-related frontotemporal dementia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ftd-chmp2b" document-type="chapter"><italic toggle="yes">CHMP2B</italic>-related frontotemporal dementia</related-object>, amyotrophic lateral sclerosis [ALS] with frontotemporal dementia [see <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>]), <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="prion" document-type="chapter">prion diseases</related-object>, <related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter">CADASIL</related-object>, and other rare neurodegenerative disorders.</p>
      </sec>
      <sec id="alzheimer-early.Management">
        <title>Management</title>
        <sec id="alzheimer-early.Evaluations_Following_In">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with early-onset familial Alzheimer disease (EOFAD), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>History (especially first symptoms, duration, progression). In particular, onset before age 45 years may indicate more rapid progression.</p>
            </list-item>
            <list-item>
              <p>Examination (especially mental status)</p>
            </list-item>
            <list-item>
              <p>MRI, PET. Severe cortical atrophy on MRI or marked metabolic deficits on PET imaging suggest more advanced disease.</p>
            </list-item>
          </list>
        </sec>
        <sec id="alzheimer-early.Treatment_of_Manifestati">
          <title>Treatment of Manifestations</title>
          <p>The mainstay of treatment is supportive and each symptom is managed on an individual basis [<xref ref-type="bibr" rid="alzheimer-early.REF.clare.2002.139">Clare 2002</xref>]. In general, affected individuals eventually require assisted living arrangements or nursing home care.</p>
          <p>Although the exact biochemical basis of Alzheimer disease is not well understood, it is known that deficiencies of the brain cholinergic system and of other neurotransmitters are present. Agents that increase cholinergic activity, such as tacrine cholinesterase inhibitors, are approved for treatment and show modest but variable benefit. Aricept<sup>&#x000ae;</sup> (donepezil), Exelon<sup>&#x000ae;</sup> (rivastigmine), and Reminyl<sup>&#x000ae;</sup> (galatamine) are such drugs [<xref ref-type="bibr" rid="alzheimer-early.REF.rogers.1998.136">Rogers et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.farlow.2000.236">Farlow et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.raskind.2000.2261">Raskind et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.feldman.2001.613">Feldman et al 2001</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.mohs.2001.481">Mohs et al 2001</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.seltzer.2004.1852">Seltzer et al 2004</xref>].</p>
          <p>Memantine, an NMDA receptor antagonist, has also been approved for use in AD [<xref ref-type="bibr" rid="alzheimer-early.REF.reisberg.2003.1333">Reisberg et al 2003</xref>].</p>
          <p>Medical and behavioral management of depression, aggression, sleep disturbance, seizures, and hallucinations is required. Depression and seizures should be treated with appropriate medications.</p>
          <p>Physical and occupational therapy can be helpful to manage problems with gait and activities of daily living.</p>
        </sec>
        <sec id="alzheimer-early.Surveillance">
          <title>Surveillance</title>
          <p>Monthly surveillance to identify and manage secondary complications is indicated.</p>
        </sec>
        <sec id="alzheimer-early.AgentsCircumstances_to_A">
          <title>Agents/Circumstances to Avoid</title>
          <p>Sudden changes in environment and over-sedation should be avoided.</p>
        </sec>
        <sec id="alzheimer-early.Evaluation_of_Relatives">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="alzheimer-early.Related_Genetic_Counseli">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="alzheimer-early.Therapies_Under_Investig">
          <title>Therapies Under Investigation</title>
          <p>Nonsteroidal anti-inflammatory drugs (NSAIDs), lipid-lowering agents, vitamin E, beta secretase inhibitors and &#x003b2; amyloid "vaccination" are being investigated as possible therapeutic agents for AD [<xref ref-type="bibr" rid="alzheimer-early.REF.lahiri.2003.97">Lahiri et al 2003</xref>]. None of these pharmacologic treatments has been systematically evaluated in individuals with EOFAD.</p>
          <p>An amyloid vaccination immunization trial of A&#x003b2;42 in late-onset AD was stopped because encephalitis developed in 6% of the subjects [<xref ref-type="bibr" rid="alzheimer-early.REF.holmes.2008.216">Holmes et al 2008</xref>].</p>
          <p>A treatment trial of an anti-A&#x003b2; monoclonal antibody showed no significant differences when primary efficacy was analyzed [<xref ref-type="bibr" rid="alzheimer-early.REF.salloway.2009.2061">Salloway et al 2009</xref>].</p>
          <p>A treatment trial with a gamma secretase inhibitor (tarenflurbil) showed no efficacy [<xref ref-type="bibr" rid="alzheimer-early.REF.green.2009.2557">Green et al 2009</xref>].</p>
          <p>Retrospective studies of NSAIDs have been mixed, showing possible protective effects [<xref ref-type="bibr" rid="alzheimer-early.REF.vlad.2008.1672">Vlad et al 2008</xref>] and no protective effects [<xref ref-type="bibr" rid="alzheimer-early.REF.breitner.2009.1899">Breitner et al 2009</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/">Clinical Trials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="alzheimer-early.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="alzheimer-early.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Early-onset familial Alzheimer disease (EOFAD) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="alzheimer-early.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed as having EOFAD have had an affected parent. Because the onset of EOFAD is typically in early adulthood and the progression is rapid, affected parents are not alive at the time of diagnosis of their children.</p>
            </list-item>
            <list-item>
              <p>Occasionally, neither parent is identified as having had the disease, but a second-degree relative (e.g., an uncle, aunt, and/or grandparent) has or had EOFAD.</p>
            </list-item>
            <list-item>
              <p>A proband with EOFAD may have the disorder as the result of a <italic toggle="yes">de novo</italic> gene mutation, although this has not been documented.</p>
            </list-item>
          </list>
          <p>Note: Although most individuals diagnosed with EOFAD have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or reduced penetrance.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband was affected or had a disease-causing mutation, the risk to sibs of having inherited the mutation is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Offspring have a 50% chance of inheriting the altered gene.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the genetic status of the proband's parents. If a parent was affected, his or her family members are at risk.</p>
        </sec>
        <sec id="alzheimer-early.Related_Genetic_Counseli">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition had the disease-causing mutation, it is likely that the proband has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk of developing EOFAD.</p>
            </list-item>
          </list>
          <p><bold>Testing of at-risk asymptomatic adults.</bold> Testing of at-risk asymptomatic adults for EOFAD is possible for <italic toggle="yes">PSEN1</italic> (presenilin-1), <italic toggle="yes">PSEN2</italic> (presenilin-2), and <italic toggle="yes">APP</italic> mutations. Such testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. When testing at-risk individuals, an affected family member should be tested first to confirm the molecular diagnosis in the family. The identification of a disease-causing mutation in an at-risk individual with equivocal symptoms does not prove or even imply that the questionable symptoms are related to the presence of the mutation.</p>
          <p>Testing for the disease-causing mutation in the absence of definite symptoms of the disease is considered predictive testing.</p>
          <p>At-risk asymptomatic adult family members may seek testing in order to make personal decisions regarding reproduction, financial matters, and career planning. Others may have different motivations including simply the "need to know." Testing of asymptomatic at-risk adult family members usually involves pre-test interviews in which the motives for requesting the test, the individual's knowledge of EOFAD, the possible impact of positive and negative test results, and neurologic status are assessed. Those seeking testing should be counseled regarding possible problems that they may encounter with regard to health, life, and disability insurance coverage, employment and educational discrimination, and changes in social and family interaction. Other issues to consider are implications for the at-risk status of other family members. Informed consent for such testing is recommended and adequate procedures should be followed to safeguard confidentiality of test results and to ensure arrangements for long-term follow up and evaluations. In a study of 21 individuals at risk for EOFAD or <related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter"><italic toggle="yes">MAPT</italic>-related disorders</related-object>, <xref ref-type="bibr" rid="alzheimer-early.REF.steinbart.2001.1828">Steinbart et al [2001]</xref> reported that most individuals undergoing <bold>presymptomatic</bold> testing demonstrated effective coping skills; long-term effects, however, are unknown.</p>
          <p><bold>Testing of at-risk individuals during childhood.</bold> Consensus holds that individuals at risk for adult-onset disorders should not have testing during childhood in the absence of symptoms. The principal arguments against testing asymptomatic individuals during childhood are that it removes their choice to know or not know this information, it raises the possibility of stigmatization within the family and in other social settings, and it may have serious educational and career implications. For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, mutations, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals</p>
        </sec>
        <sec id="alzheimer-early.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the disease-causing mutation has been identified in the family, prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis (usually performed at ~15-18 weeks&#x02019; gestation) or chorionic villus sampling (usually performed at ~10-12 weeks&#x02019; gestation).</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p>Requests for prenatal testing for typically adult-onset conditions such as EOFAD are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> and embryo transfer have been successfully used to achieve a pregnancy in a 30-year-old asymptomatic woman with an <italic toggle="yes">APP</italic> disease-causing mutation, resulting in the birth of a healthy child who does not have the <italic toggle="yes">APP</italic> disease-causing mutation identified in the mother and her family [<xref ref-type="bibr" rid="alzheimer-early.REF.verlinsky.2002.1018">Verlinsky et al 2002</xref>]. <xref ref-type="bibr" rid="alzheimer-early.REF.towner.2002.1038">Towner &#x00026; Loewy [2002]</xref> and <xref ref-type="bibr" rid="alzheimer-early.REF.spriggs.2002.290">Spriggs [2002]</xref> identify some of the ethical issues arising from the decisions of parents and health care providers.</p>
          <p>Preimplantation genetic diagnosis may be an option for some families in which the disease-causing mutation has been identified. </p>
        </sec>
      </sec>
      <sec id="alzheimer-early.Resources">
        <title>Resources</title>
      </sec>
      <sec id="alzheimer-early.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">APP</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">APP</italic> has 19 exons and encodes a large precursor protein of 695-770 amino acids that is proteolytically cleaved to form A-beta peptide. Alternative <italic toggle="yes">APP</italic> transcripts are often designated by the number of amino acids they encode, e.g., APP770 transcript or <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/41406053">NM_000484.2</ext-link>. The A-beta peptide portion is encoded by parts of exons 16 and 17; these exons encode codons 655-737. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="alzheimer-early" object-id="alzheimer-early.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> The most common <italic toggle="yes">APP</italic> mutation is p.Val717Ile. Substitutions of phenylalanine and glycine may also occur at this codon. A two-nucleotide indel (insertion and deletion) in exon 16 (c.2010_2011delinsTC) produces the so-called Swedish mutation (see <xref ref-type="table" rid="alzheimer-early.T.selected_app_pathogeni">Table 2</xref>).</p>
        <p><italic toggle="yes">APP</italic> duplication has been reported in a few families (see <xref ref-type="sec" rid="alzheimer-early.GenotypePhenotype_Correl">Genotype-Phenotype Correlations</xref>).</p>
        <table-wrap id="alzheimer-early.T.selected_app_pathogeni" position="anchor" orientation="portrait">
          <label>Table 2.</label>
          <caption>
            <p>Selected <italic toggle="yes">APP</italic> Pathogenic Variants</p>
          </caption>
          <table>
            <tbody>
              <tr>
                <th id="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.2149G&#x0003e;A </td>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Val717Ile </td>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_3" align="left" valign="middle" rowspan="5" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/41406053">NM_000484.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4502167">NP_000475.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.2010_2011delinsTC</td>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Lys670_Met671delinsAsnLeu</td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.2075C&#x0003e;G </td>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ala692Gly&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.2018C&#x0003e;T</td>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ala673Val&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.2078A&#x0003e;G&#x000a0;<sup>2</sup></td>
                <td headers="hd_b_alzheimer-early.T.selected_app_pathogeni_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Glu693Gly&#x000a0;<sup>1,</sup>&#x000a0;<sup>2</sup></td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature. 1. See <xref ref-type="sec" rid="alzheimer-early.GenotypePhenotype_Correl">Genotype-Phenotype Correlations</xref>.2. Mutation associated with cerebral hemorrhagic amyloidosis of the Dutch type</p>
        <p><bold>Normal gene product.</bold> The protein encoded for by <italic toggle="yes">APP</italic>, amyloid-&#x003b2; A4 protein, contains 695 to 770 amino acids and undergoes alternative splicing. A 57-amino-acid portion is homologous to Kunitz-type protease inhibitors. The major transcripts in peripheral tissues are the APP751 and APP770 variants. The A-beta peptide contains 38 to 42 amino acids and resides in the transmembrane domain of the protein. Amyloid-&#x003b2; A4 protein may be cleaved by an alpha secretase within the amyloid-&#x003b2; peptide sequence, thus eliminating the possibility of amyloid-&#x003b2; accumulation. However, amyloid-&#x003b2; A4 may also be cleaved by beta and gamma secretases that result in the accumulation of amyloid-&#x003b2; peptide.</p>
        <p><bold>Abnormal gene product.</bold> Imbalance in cleavage produces excess of longer amyloid beta peptide isoforms that are neurotoxic and prone to self-aggregation.</p>
        <p>
          <bold>
            <italic toggle="yes">PSEN1</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold> The coding region is composed of ten exons numbered 3 through 12. Exon 8 and part of exon 3 are alternatively spliced, so shorter isoforms of the protein are predicted to exist. Alternative splicing may also introduce a new exon between exons 10 and 11. <italic toggle="yes">PSEN1</italic> and <italic toggle="yes">PSEN2</italic> are highly homologous. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="alzheimer-early" object-id="alzheimer-early.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> More than 40 mutations that result in EOFAD have been described in more than 50 families [<xref ref-type="bibr" rid="alzheimer-early.REF.cruts.1998.43">Cruts et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.cruts.1998.183">Cruts &#x00026; Van Broeckhoven 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.poorkaj.1998.216">Poorkaj et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.larner.2006.139">Larner &#x00026; Doran 2006</xref>]. The majority are missense mutations. One exception is a mutation eliminating a splice site in which exon 9 is lost but the reading frame is unaltered and the protein is predicted to be 29 amino acids shorter. A genomic deletion spanning exon 9 is also found in the Finnish population. At least nine mutations occur in a cytosolic domain between transmembrane domains 6 and 7 and the rest of the mutations are within the other hydrophobic domains or immediately at the hydrophilic/hydrophobic junctions, especially of transmembrane domain 2. The relative frequency of mutations in the cytosolic domain encoded by the alternatively spliced exon 8 suggests that this region of the protein is functionally important (see <xref ref-type="table" rid="alzheimer-early.T.selected_psen1_pathoge">Table 3</xref>).</p>
        <table-wrap id="alzheimer-early.T.selected_psen1_pathoge" position="anchor" orientation="portrait">
          <label>Table 3.</label>
          <caption>
            <p>Selected <italic toggle="yes">PSEN1</italic> Pathogenic Variants</p>
          </caption>
          <table>
            <tbody>
              <tr>
                <th id="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences </th>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.236C&#x0003e;T </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ala79Val&#x000a0;<sup>1</sup></td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_3" align="left" valign="middle" rowspan="14" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/195947402">NM_000021.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4506163">NP_000012.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.265G&#x0003e;T </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Val89Leu&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.338T&#x0003e;C </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Leu113Pro&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.415A&#x0003e;G </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Met139Val&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.436A&#x0003e;C </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Met146Leu </td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.509C&#x0003e;T </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ser170Phe&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.548G&#x0003e;T </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Gly183Val </td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.697A&#x0003e;G </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Met233Val&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.767A&#x0003e;C </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Tyr256Ser&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.806G&#x0003e;A</td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Arg269His&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.839A&#x0003e;C </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Glu280Ala&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1175T&#x0003e;C </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Leu392Pro&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1292C&#x0003e;A </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ala431Glu </td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">4,555-bp deletion of exon 9</td>
                <td headers="hd_b_alzheimer-early.T.selected_psen1_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">See footnotes 1 and 3</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="alzheimer-early.TF.2">
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
            </fn>
            <fn id="alzheimer-early.TF.2.1">
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature. </p>
            </fn>
            <fn id="alzheimer-early.TF.2.2">
              <p>1. See <xref ref-type="sec" rid="alzheimer-early.GenotypePhenotype_Correl">Genotype-Phenotype Correlations</xref>.</p>
            </fn>
            <fn id="alzheimer-early.TF.2.3">
              <p>2. See <xref ref-type="sec" rid="alzheimer-early.Prevalence">Prevalence</xref>.</p>
            </fn>
            <fn id="alzheimer-early.TF.2.4">
              <p>3. <xref ref-type="bibr" rid="alzheimer-early.REF.prihar.1999.1090">Prihar et al [1999]</xref></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">PSEN1</italic> is predicted to encode a 467-amino acid protein with between seven and ten (probably eight) hydrophobic transmembrane domains. The presenilin-1 protein is highly homologous to the presenilin-2 protein; the regions of greatest divergence are between the two large hydrophilic loops, one at the amino terminal end and the other in the cytosolic domain between the sixth and seventh transmembrane domains [<xref ref-type="bibr" rid="alzheimer-early.REF.tandon.2002.1">Tandon &#x00026; Fraser 2002</xref>]. This cytosolic domain contains a proteolytic cleavage site [<xref ref-type="bibr" rid="alzheimer-early.REF.podlisny.1997.325">Podlisny et al 1997</xref>]. The protein is a functional homolog of SEL-12, a <italic toggle="yes">C elegans</italic> protein that facilitates signaling mediated by the Notch/LIN-12 receptor family [<xref ref-type="bibr" rid="alzheimer-early.REF.wong.1997.288">Wong et al 1997</xref>]. The protein acts as part of the gamma secretase cleavage system for amyloid-&#x003b2; A4 protein. <italic toggle="yes">PS1</italic> knockout mice die in utero and have severe skeletal abnormalities [<xref ref-type="bibr" rid="alzheimer-early.REF.shen.1997.629">Shen et al 1997</xref>]. The presenilins cleave other proteins in addition to amyloid-&#x003b2; A4 protein [<xref ref-type="bibr" rid="alzheimer-early.REF.thinakaran.2004.411">Thinakaran &#x00026; Parent 2004</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Abnormal <italic toggle="yes">PSEN1</italic> results in increased production of the longer isoforms of amyloid-&#x003b2; peptide, which are neurotoxic and prone to self-aggregation [<xref ref-type="bibr" rid="alzheimer-early.REF.jankowsky.2004.159">Jankowsky et al 2004</xref>]. Some mutations may result in loss of the gamma secretase function of presenilin-1 [<xref ref-type="bibr" rid="alzheimer-early.REF.destrooper.2007.141">De Strooper 2007</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.shen.2007.403">Shen &#x00026; Kelleher 2007</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">PSEN2</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">PSEN2</italic> is highly homologous to <italic toggle="yes">PSEN1</italic>. It includes 12 exons with ten coding exons in a genomic region spanning 23,737 bp. The first two exons encode the 5' untranslated region. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="alzheimer-early" object-id="alzheimer-early.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> A single mutation (p.Asn141Ile) has been found in several Volga German FAD pedigrees, confirming the founder effect in this population. Another mutation (p.Met239Val) has been reported in an Italian kindred with FAD [<xref ref-type="bibr" rid="alzheimer-early.REF.rogaev.1995.775">Rogaev et al 1995</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.marcon.2004.199">Marcon et al 2004</xref>] (see <xref ref-type="table" rid="alzheimer-early.T.selected_psen2_pathoge">Table 4</xref>). A few additional and possibly pathogenic variants have been reported [<xref ref-type="bibr" rid="alzheimer-early.REF.beyer.1998.587">Beyer et al 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.cruts.1998.183">Cruts &#x00026; Van Broeckhoven 1998</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.tedde.2003.1541">Tedde et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.zekanowski.2003.991">Zekanowski et al 2003</xref>].</p>
        <table-wrap id="alzheimer-early.T.selected_psen2_pathoge" position="anchor" orientation="portrait">
          <label>Table 4.</label>
          <caption>
            <p>Selected <italic toggle="yes">PSEN2</italic> Pathogenic Variants</p>
          </caption>
          <table>
            <tbody>
              <tr>
                <th id="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.422A&#x0003e;T </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Asn141Ile&#x000a0;<sup>1</sup></td>
                <td headers="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_3" align="left" valign="middle" rowspan="2" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/156105678">NM_000447.2</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/156105679">NP_000438.2</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.717G&#x0003e;A </td>
                <td headers="hd_b_alzheimer-early.T.selected_psen2_pathoge_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Met239Val </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="alzheimer-early.TF.3">
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
            </fn>
            <fn id="alzheimer-early.TF.3.1">
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature. </p>
            </fn>
            <fn id="alzheimer-early.TF.3.2">
              <p>1. See <xref ref-type="sec" rid="alzheimer-early.Prevalence">Prevalence</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">PSEN2</italic> is predicted to encode a 448-amino acid protein that is highly homologous to the presenilin-1 protein. The presenilin-2 protein is also thought to contain eight transmembrane domains. The regions of greatest divergence between the two proteins are at the amino terminal end and in the cytosolic domain between the sixth and seventh transmembrane domains [<xref ref-type="bibr" rid="alzheimer-early.REF.uemura.2003.184">Uemura et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.thinakaran.2004.411">Thinakaran &#x00026; Parent 2004</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Presumably similar to that noted for <italic toggle="yes">PSEN1</italic> mutations [<xref ref-type="bibr" rid="alzheimer-early.REF.jankowsky.2004.159">Jankowsky et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.walker.2005.294">Walker et al 2005</xref>, <xref ref-type="bibr" rid="alzheimer-early.REF.destrooper.2007.141">De Strooper 2007</xref>]</p>
      </sec>
      <sec id="alzheimer-early.References">
        <title>References</title>
        <sec id="alzheimer-early.Published_GuidelinesCons">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="alzheimer-early.Published_GuidelinesCons.reflist0">
            <ref id="alzheimer-early.REF.americansocie.1995.1">
              <mixed-citation publication-type="book">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 2-18-15.</mixed-citation>
            </ref>
            <ref id="alzheimer-early.REF.nationalsocie.2012.1">
              <mixed-citation publication-type="book">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 4-7-14.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="alzheimer-early.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="alzheimer-early.Literature_Cited.reflist0">
            <ref id="alzheimer-early.REF.ataka.2004.1773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ataka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomiyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takuma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsutada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawabata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miki</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis.</article-title>
                <source>Arch Neurol.</source>
                <year>2004</year>
                <volume>61</volume>
                <fpage>1773</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15534188</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.athan.2001.2257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Athan</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciappa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romas</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rondon</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lantigua</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medrano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arawaka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>YQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawarai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fafel</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boss</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seltzer</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stern</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tycko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayeux</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.</article-title>
                <source>JAMA</source>
                <year>2001</year>
                <volume>286</volume>
                <fpage>2257</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">11710891</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.basun.2008.499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Basun</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bogdanovic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingelsson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almkvist</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000e4;slund</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axelman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahlund</surname>
                    <given-names>LO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lannfelt</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.</article-title>
                <source>Arch Neurol.</source>
                <year>2008</year>
                <volume>65</volume>
                <fpage>499</fpage>
                <lpage>505</lpage>
                <pub-id pub-id-type="pmid">18413473</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.bateman.2012.795">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bateman</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiong</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benzinger</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagan</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcus</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairns</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazey</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holtzman</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santacruz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckles</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moulder</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aisen</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klunk</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDade</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masters</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayeux</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salloway</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <publisher-name>Dominantly Inherited Alzheimer Network.</publisher-name>
                <article-title>Clinical and biomarker changes in dominantly inherited Alzheimer's disease.</article-title>
                <source>N Engl J Med.</source>
                <year>2012</year>
                <volume>367</volume>
                <fpage>795</fpage>
                <lpage>804</lpage>
                <pub-id pub-id-type="pmid">22784036</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.beck.2004.1219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beck</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uphill</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geddes</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revesz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collinge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabrizi</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2004</year>
                <volume>13</volume>
                <fpage>1219</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15115757</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.beyer.1998.587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beyer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lao</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Novoa</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <etal/>
                <article-title>Identification of a novel mutation (V148I) in the TM2 domain of the presenilin 2 gene in a patient with late-onset AD.</article-title>
                <source>Neurobiol Aging</source>
                <year>1998</year>
                <volume>19</volume>
                <supplement>Suppl 2</supplement>
                <fpage>587</fpage>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.bird.1988.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampe</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemens</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miner</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <article-title>Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect.</article-title>
                <source>Ann Neurol.</source>
                <year>1988</year>
                <volume>23</volume>
                <fpage>25</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">3345066</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.bird.1996.932">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy-Lahad</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poorkaj</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemens</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampe</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <article-title>Wide range in age of onset for chromosome 1--related familial Alzheimer's disease.</article-title>
                <source>Ann Neurol.</source>
                <year>1996</year>
                <volume>40</volume>
                <fpage>932</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9007102</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.blom.2008.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viswanathan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilander</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helisalmi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soininen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lannfelt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingelsson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiltunen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2008</year>
                <volume>16</volume>
                <fpage>171</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18043715</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.breitner.2009.1899">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Breitner</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haneuse</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dublin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crane</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>EB</given-names>
                  </name>
                </person-group>
                <article-title>Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.</article-title>
                <source>Neurology.</source>
                <year>2009</year>
                <volume>72</volume>
                <fpage>1899</fpage>
                <lpage>905</lpage>
                <pub-id pub-id-type="pmid">19386997</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.brickell.2007.1050">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brickell</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leverenz</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumbaugh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampe</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deerlin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2007</year>
                <volume>78</volume>
                <fpage>1050</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17615170</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.brickell.2006.1307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brickell</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumbaugh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deerlin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.</article-title>
                <source>Arch Neurol.</source>
                <year>2006</year>
                <volume>63</volume>
                <fpage>1307</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16966510</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.brooks.2003.783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kril</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broe</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumbergs</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tannenberg</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamont</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedges</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <article-title>Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions.</article-title>
                <source>Brain.</source>
                <year>2003</year>
                <volume>126</volume>
                <fpage>783</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">12615638</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.campion.1999.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campion</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumanchin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belliard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas-Anterion</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbonnier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesnage</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clerget-Darpoux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1999</year>
                <volume>65</volume>
                <fpage>664</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10441572</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.clare.2002.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clare</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>We'll fight it as long as we can: coping with the onset of Alzheimer's disease.</article-title>
                <source>Aging Ment Health.</source>
                <year>2002</year>
                <volume>6</volume>
                <fpage>139</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">12028882</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.crook.1998.452">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crook</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verkkoniemi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Tur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gwinn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ylikoski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000f6;yh&#x000f6;nen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kucera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haltia</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.</article-title>
                <source>Nat Med.</source>
                <year>1998</year>
                <volume>4</volume>
                <fpage>452</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9546792</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.cruts.1998.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cruts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Presenilin mutations in Alzheimer's disease.</article-title>
                <source>Hum Mutat.</source>
                <year>1998</year>
                <volume>11</volume>
                <fpage>183</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">9521418</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.cruts.1998.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cruts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Backhovens</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Broeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wehnert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serneels</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherrington</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.</article-title>
                <source>Hum Mol Genet.</source>
                <year>1998</year>
                <volume>7</volume>
                <fpage>43</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">9384602</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.cummings.1998.S2">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinters</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khachaturian</surname>
                    <given-names>ZS</given-names>
                  </name>
                </person-group>
                <article-title>Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities.</article-title>
                <source>Neurology.</source>
                <year>1998</year>
                <volume>51</volume>
                <fpage>S2</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">9674758</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.destrooper.2007.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Strooper</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Loss-of-function presenilin mutations in Alzheimer disease. Talking point on the role of presenilin mutations in Alzheimer disease.</article-title>
                <source>EMBO Rep.</source>
                <year>2007</year>
                <volume>8</volume>
                <fpage>141</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17268505</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.dermaut.2004.617">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dermaut</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar-Singh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelborghs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theuns</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saerens</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pickut</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeters</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Broeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vennekens</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cras</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Deyn</surname>
                    <given-names>PP</given-names>
                  </name>
                </person-group>
                <article-title>A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques.</article-title>
                <source>Ann Neurol.</source>
                <year>2004</year>
                <volume>55</volume>
                <fpage>617</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">15122701</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.difede.2009.1473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Fede</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catania</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suardi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzoleni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giovagnoli</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prioni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erbetta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falcone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzoni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francescucci</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spagnoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant&#x000f9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Favero</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmona</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagliavini</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis.</article-title>
                <source>Science.</source>
                <year>2009</year>
                <volume>323</volume>
                <fpage>1473</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19286555</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.farlow.2000.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anand</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veach</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.</article-title>
                <source>Eur Neurol.</source>
                <year>2000</year>
                <volume>44</volume>
                <fpage>236</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11096224</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.feldman.2001.613">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauthier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hecker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vellas</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subbiah</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whalen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <publisher-name>Donepezil MSAD Study Investigators Group</publisher-name>
                <article-title>A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.</article-title>
                <source>Neurology.</source>
                <year>2001</year>
                <volume>57</volume>
                <fpage>613</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">11524468</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.finckh.2000.2006">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alberici</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoniazzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benussi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fedi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nitsch</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binetti</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I.</article-title>
                <source>Neurology.</source>
                <year>2000</year>
                <volume>54</volume>
                <fpage>2006</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10822446</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.fox.1997.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lantos</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roques</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collinge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warrington</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                </person-group>
                <article-title>Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.</article-title>
                <source>Brain.</source>
                <year>1997</year>
                <volume>120</volume>
                <fpage>491</fpage>
                <lpage>501</lpage>
                <pub-id pub-id-type="pmid">9126060</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.furuya.2003.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furuya</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terasawa</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kira</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohyagi</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation (L250V) in the presenilin 1 gene in a Japanese familial Alzheimer's disease with myoclonus and generalized convulsion.</article-title>
                <source>J Neurol Sci.</source>
                <year>2003</year>
                <volume>209</volume>
                <fpage>75</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12686406</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.giaccone.2010.803">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giaccone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moda</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzoleni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uggetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catania</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moro</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redaelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spagnoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmona</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Fede</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagliavini</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features.</article-title>
                <source>Acta Neuropathol</source>
                <year>2010</year>
                <volume>120</volume>
                <fpage>803</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">20842367</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.godbolt.2004.1743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Godbolt</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cipolotti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watt</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                </person-group>
                <article-title>The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.</article-title>
                <source>Arch Neurol.</source>
                <year>2004</year>
                <volume>61</volume>
                <fpage>1743</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15534185</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.gomezisla.1999.1709">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-Isla</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Growdon</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNamara</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arango</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopera</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosik</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lantos</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairns</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyman</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <article-title>The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.</article-title>
                <source>Brain.</source>
                <year>1999</year>
                <volume>122</volume>
                <fpage>1709</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">10468510</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.green.2009.2557">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amato</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beelen</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcock</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swabb</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zavitz</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.</article-title>
                <source>JAMA</source>
                <year>2009</year>
                <volume>302</volume>
                <fpage>2557</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">20009055</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.gustafson.1998.253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gustafson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brun</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Englund</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagnell</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilsson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stensmyr</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlin</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrahamson</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>A 50-year perspective of a family with chromosome-14-linked Alzheimer's disease.</article-title>
                <source>Hum Genet.</source>
                <year>1998</year>
                <volume>102</volume>
                <fpage>253</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9544835</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.guyantmare.2008.1925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guyant-Marechal</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laquerri&#x000e8;re</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rovelet-Lecrux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viennet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumbach</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campion</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Intrafamilial diversity of phenotype associated with app duplication.</article-title>
                <source>Neurology.</source>
                <year>2008</year>
                <volume>71</volume>
                <fpage>1925</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19047566</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.halliday.2005.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Halliday</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lepar</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kersaitis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahimi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kril</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Pick bodies in a family with presenilin-1 Alzheimer's disease.</article-title>
                <source>Ann Neurol.</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>139</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">15622541</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.hattori.2004.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakuma</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakutani</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimoda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urakami</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakashima</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer's disease with spastic paraparesis.</article-title>
                <source>Neurosci Lett.</source>
                <year>2004</year>
                <volume>368</volume>
                <fpage>319</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15364419</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.heckmann.2004.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heckmann</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Villiers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutherfoord</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorster</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesar</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaria</surname>
                    <given-names>RN</given-names>
                  </name>
                </person-group>
                <article-title>Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease.</article-title>
                <source>Brain.</source>
                <year>2004</year>
                <volume>127</volume>
                <fpage>133</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">14570818</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.holmes.2008.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boche</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkinson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yadegarfar</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bullock</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Love</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neal</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zotova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicoll</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.</article-title>
                <source>Lancet.</source>
                <year>2008</year>
                <volume>372</volume>
                <fpage>216</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">18640458</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.jankowsky.2004.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jankowsky</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadale</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Younkin</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Younkin</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borchelt</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <article-title>Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2004</year>
                <volume>13</volume>
                <fpage>159</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">14645205</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.janssen.2003.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beck</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickinson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collinge</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Early onset familial Alzheimer's disease: Mutation frequency in 31 families.</article-title>
                <source>Neurology.</source>
                <year>2003</year>
                <volume>60</volume>
                <fpage>235</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12552037</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.jayadev.2010.1143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jayadev</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leverenz</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stahl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klunk</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.</article-title>
                <source>Brain.</source>
                <year>2010</year>
                <volume>133</volume>
                <fpage>1143</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20375137</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.kauwe.2007.446">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kauwe</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquart</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakraverty</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagan</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holtzman</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.</article-title>
                <source>Ann Neurol.</source>
                <year>2007</year>
                <volume>61</volume>
                <fpage>446</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">17366635</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.klunk.2007.6174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klunk</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsopelas</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopresti</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ziolko</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoge</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikonomovic</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saxton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snitz</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollen</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moonis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lippa</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swearer</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rentz</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischman</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aizenstein</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeKosky</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <article-title>Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.</article-title>
                <source>J Neurosci.</source>
                <year>2007</year>
                <volume>27</volume>
                <fpage>6174</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">17553989</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.kowalska.2003.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kowalska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wender</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florczak</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruchnik-Wolinska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modestowicz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szczech</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozubski</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Molecular genetics of Alzheimer's disease: presenilin 1 gene analysis in a cohort of patients from the Pozna&#x00144; region.</article-title>
                <source>J Appl Genet.</source>
                <year>2003</year>
                <volume>44</volume>
                <fpage>231</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12817569</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.lahiri.2003.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lahiri</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sambamurti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greig</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giacobini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <article-title>A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.</article-title>
                <source>Curr Drug Targets.</source>
                <year>2003</year>
                <volume>4</volume>
                <fpage>97</fpage>
                <lpage>112</lpage>
                <pub-id pub-id-type="pmid">12558063</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.larner.2006.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Larner</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doran</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.</article-title>
                <source>J Neurol.</source>
                <year>2006</year>
                <volume>253</volume>
                <fpage>139</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">16267640</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.larner.2007.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Larner</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doran</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease.</article-title>
                <source>J Neurol Sci.</source>
                <year>2007</year>
                <volume>252</volume>
                <fpage>173</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17188713</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.leverenz.2006.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leverenz</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peskind</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montine</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuang</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.</article-title>
                <source>Arch Neurol.</source>
                <year>2006</year>
                <volume>63</volume>
                <fpage>370</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16533963</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.li.2006.1030">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parks</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushner</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nauman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgess</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwigsen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Partain</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nixon</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irwin</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershberger</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Mutations of presenilin genes in dilated cardiomyopathy and heart failure.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2006</year>
                <volume>79</volume>
                <fpage>1030</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17186461</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.lippa.2000.376">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lippa</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swearer</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kane</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nee</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollen</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drachman</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>Familial Alzheimer's disease: site of mutation influences clinical phenotype.</article-title>
                <source>Ann Neurol.</source>
                <year>2000</year>
                <volume>48</volume>
                <fpage>376</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10976645</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.lleo.2001.1926">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lle&#x000f3;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blesa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gendre</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellv&#x000ed;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastor</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Queralt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliva</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer's disease.</article-title>
                <source>Neurology.</source>
                <year>2001</year>
                <volume>57</volume>
                <fpage>1926</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11723295</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.lleo.2002.1759">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lle&#x000f3;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blesa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Queralt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ezquerra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molinuevo</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000f1;a-Casanova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rojo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliva</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.</article-title>
                <source>Arch Neurol.</source>
                <year>2002</year>
                <volume>59</volume>
                <fpage>1759</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">12433263</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.maarouf.2008.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maarouf</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daugs</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spina</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kokjohn</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patton</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalback</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luehrs</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casta&#x000f1;o</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beach</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roher</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <article-title>Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations.</article-title>
                <source>Mol Neurodegener.</source>
                <year>2008</year>
                <volume>3</volume>
                <fpage>20</fpage>
                <pub-id pub-id-type="pmid">19021905</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.mann.1997.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwatsubo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy-Lahad</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>Amyloid (Abeta) deposition in chromosome 1-linked Alzheimer's disease: the Volga German families.</article-title>
                <source>Ann Neurol.</source>
                <year>1997</year>
                <volume>41</volume>
                <fpage>52</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9005865</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.marcon.2004.199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marcon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giaccone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cupidi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balestrieri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beltrami</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finato</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergonzi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorbi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagliavini</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene.</article-title>
                <source>J Neuropathol Exp Neurol.</source>
                <year>2004</year>
                <volume>63</volume>
                <fpage>199</fpage>
                <lpage>209</lpage>
                <pub-id pub-id-type="pmid">15055444</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.menendez.2004.475">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Men&#x000e9;ndez</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Pathological and clinical heterogeneity of presenilin 1 gene mutations.</article-title>
                <source>J Alzheimers Dis.</source>
                <year>2004</year>
                <volume>6</volume>
                <fpage>475</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15505368</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.miklossy.2003.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miklossy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taddei</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suva</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verdile</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gnjec</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghika</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masters</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>RN</given-names>
                  </name>
                </person-group>
                <article-title>Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease.</article-title>
                <source>Neurobiol Aging.</source>
                <year>2003</year>
                <volume>24</volume>
                <fpage>655</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">12885573</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.mohs.2001.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mohs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ieni</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perdomo</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pratt</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <article-title>A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients.</article-title>
                <source>Neurology.</source>
                <year>2001</year>
                <volume>57</volume>
                <fpage>481</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11502917</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.moonis.2005.323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moonis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swearer</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dayaw</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawarai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollen</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline.</article-title>
                <source>Neurology.</source>
                <year>2005</year>
                <volume>65</volume>
                <fpage>323</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16043812</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.nationalins.1998.109">
              <element-citation publication-type="journal">
                <publisher-name>National Institute on Aging Working Group</publisher-name>
                <article-title>Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.</article-title>
                <source>Neurobiol Aging.</source>
                <year>1998</year>
                <volume>19</volume>
                <fpage>109</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9558143</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.nikisch.2008.579">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikisch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiessling</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiedemann</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.</article-title>
                <source>Eur J Med Res.</source>
                <year>2008</year>
                <volume>13</volume>
                <fpage>579</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">19073399</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.nilsberth.2001.887">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nilsberth</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westlind-Danielsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckman</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Condron</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axelman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luthman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teplow</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Younkin</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000e4;slund</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lannfelt</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.</article-title>
                <source>Nat Neurosci.</source>
                <year>2001</year>
                <volume>4</volume>
                <fpage>887</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">11528419</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.pastor.2003.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pastor</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roe</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villegas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedoya</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakraverty</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirado</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000ed;os</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosik</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopera</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.</article-title>
                <source>Ann Neurol.</source>
                <year>2003</year>
                <volume>54</volume>
                <fpage>163</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12891668</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.pereztur.1995.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perez-Tur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froelich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prihar</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crook</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duff</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wragg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busfield</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lendon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>RF</given-names>
                  </name>
                </person-group>
                <etal/>
                <article-title>A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene.</article-title>
                <source>Neuroreport.</source>
                <year>1995</year>
                <volume>7</volume>
                <fpage>297</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">8742474</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.piccini.2007.738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piccini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanusso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borghi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noviello</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damonte</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armirotti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelati</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambenedetti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabaton</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype.</article-title>
                <source>Arch Neurol.</source>
                <year>2007</year>
                <volume>64</volume>
                <fpage>738</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">17502474</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.podlisny.1997.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Podlisny</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Citron</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amarante</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherrington</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diehl</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levesque</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraser</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haass</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koo</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seubert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teplow</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selkoe</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title>Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.</article-title>
                <source>Neurobiol Dis.</source>
                <year>1997</year>
                <volume>3</volume>
                <fpage>325</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">9173929</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.poorkaj.1998.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poorkaj</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemens</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orr</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heston</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <article-title>Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene.</article-title>
                <source>Hum Mutat.</source>
                <year>1998</year>
                <volume>11</volume>
                <fpage>216</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">9521423</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.prihar.1999.1090">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prihar</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verkkoniem</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Tur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crook</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grover</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllykangas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haltia</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Alzheimer disease PS-1 exon 9 deletion defined.</article-title>
                <source>Nat Med.</source>
                <year>1999</year>
                <volume>5</volume>
                <fpage>1090</fpage>
                <pub-id pub-id-type="pmid">10502791</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.queralt.2002.266">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Queralt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ezquerra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lle&#x000f3;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellv&#x000ed;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelp&#x000ed;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acar&#x000ed;n</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasar&#x000ed;n</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blesa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliva</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2002</year>
                <volume>72</volume>
                <fpage>266</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11796781</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.raman.2007.78">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hewitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Constantinescu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>A presenilin 1 mutation (Arg278Ser) associated with early onset Alzheimer's disease and spastic paraparesis.</article-title>
                <source>J Neurol Sci.</source>
                <year>2007</year>
                <volume>260</volume>
                <fpage>78</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17507029</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.raskind.2000.2261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peskind</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.</article-title>
                <source>Neurology.</source>
                <year>2000</year>
                <volume>54</volume>
                <fpage>2261</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10881250</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.raux.2000.1577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gantier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas-Anterion</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulliat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verpillat</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campion</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation.</article-title>
                <source>Neurology.</source>
                <year>2000</year>
                <volume>55</volume>
                <fpage>1577</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11094121</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.reisberg.2003.1333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reisberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;ffler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferris</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;bius</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <publisher-name>Memantine Study Group</publisher-name>
                <article-title>Memantine in moderate-to-severe Alzheimer's disease.</article-title>
                <source>N Engl J Med.</source>
                <year>2003</year>
                <volume>348</volume>
                <fpage>1333</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">12672860</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.revesz.1997.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Revesz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLaughlin</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lantos</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <article-title>Pathology of familial Alzheimer's disease with Lewy bodies.</article-title>
                <source>J Neural Transm Suppl.</source>
                <year>1997</year>
                <volume>51</volume>
                <fpage>121</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">9470133</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.ringman.2005.552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ringman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz-Olavarrieta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chavez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fairbanks</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varpetian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maldonado</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macias-Islas</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawas</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Neuropsychological function in nondemented carriers of presenilin-1 mutations.</article-title>
                <source>Neurology.</source>
                <year>2005</year>
                <volume>65</volume>
                <fpage>552</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16116115</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.rippon.2003.884">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rippon</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crook</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halvorsen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia.</article-title>
                <source>Arch Neurol.</source>
                <year>2003</year>
                <volume>60</volume>
                <fpage>884</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12810495</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.rogaev.1995.775">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rogaev</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherrington</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levesque</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuda</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <etal/>
                <article-title>Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.</article-title>
                <source>Nature.</source>
                <year>1995</year>
                <volume>376</volume>
                <fpage>775</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7651536</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.rogaeva.2001.621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fafel</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>YQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medeiros</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaev</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frommelt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadovnick</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschino</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rockwood</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boss</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayeux</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations.</article-title>
                <source>Neurology.</source>
                <year>2001</year>
                <volume>57</volume>
                <fpage>621</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11524469</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.rogers.1998.136">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohs</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedhoff</surname>
                    <given-names>LT</given-names>
                  </name>
                </person-group>
                <article-title>A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.</article-title>
                <source>Neurology.</source>
                <year>1998</year>
                <volume>50</volume>
                <fpage>136</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">9443470</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.roks.2000.2130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roks</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Harskamp</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Koning</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar-Singh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tibben</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanghe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niermeijer</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Swieten</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <article-title>Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692).</article-title>
                <source>Brain.</source>
                <year>2000</year>
                <volume>123</volume>
                <fpage>2130</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">11004129</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.roveletlecru.2006.24">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rovelet-Lecrux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Meur</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laquerri&#x000e8;re</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vital</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumanchin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feuillette</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vercelletto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campion</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.</article-title>
                <source>Nat Genet.</source>
                <year>2006</year>
                <volume>38</volume>
                <fpage>24</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16369530</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.salloway.2009.2061">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salloway</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blennow</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabbagh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honig</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dyck</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulnard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barakos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregg</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lieberburg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schenk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grundman</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <publisher-name>Bapineuzumab 201 Clinical Trial Investigators</publisher-name>
                <article-title>A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.</article-title>
                <source>Neurology.</source>
                <year>2009</year>
                <volume>73</volume>
                <fpage>2061</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19923550</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.seltzer.2004.1852">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seltzer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zolnouni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ieni</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.</article-title>
                <source>Arch Neurol.</source>
                <year>2004</year>
                <volume>61</volume>
                <fpage>1852</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15596605</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.shen.1997.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bronson</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selkoe</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonegawa</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Skeletal and CNS defects in Presenilin-1-deficient mice.</article-title>
                <source>Cell.</source>
                <year>1997</year>
                <volume>89</volume>
                <fpage>629</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">9160754</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.shen.2007.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelleher</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2007</year>
                <volume>104</volume>
                <fpage>403</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17197420</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.sleegers.2006.2977">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sleegers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwers</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gijselinck</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theuns</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wauters</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del-Favero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy.</article-title>
                <source>Brain.</source>
                <year>2006</year>
                <volume>129</volume>
                <fpage>2977</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">16921174</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.smith.2001.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kril</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broe</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappai</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallupp</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotton</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masters</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>WS</given-names>
                  </name>
                </person-group>
                <article-title>Variable phenotype of Alzheimer's disease with spastic paraparesis.</article-title>
                <source>Ann Neurol.</source>
                <year>2001</year>
                <volume>49</volume>
                <fpage>125</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11198283</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.spriggs.2002.290">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spriggs</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Genetically selected baby free of inherited predisposition to early-onset Alzheimer's disease.</article-title>
                <source>J Med Ethics.</source>
                <year>2002</year>
                <volume>28</volume>
                <fpage>290</fpage>
                <pub-id pub-id-type="pmid">12356954</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.steinbart.2001.1828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poorkaj</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia.</article-title>
                <source>Arch Neurol.</source>
                <year>2001</year>
                <volume>58</volume>
                <fpage>1828</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11708991</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.tandon.2002.1">
              <mixed-citation publication-type="book">Tandon A, Fraser P. The presenilins. Genome Biol. 2002; 3:reviews3014. </mixed-citation>
            </ref>
            <ref id="alzheimer-early.REF.tedde.2000.1590">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tedde</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forleo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nacmias</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bracco</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piacentini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorbi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset.</article-title>
                <source>Neurology.</source>
                <year>2000</year>
                <volume>55</volume>
                <fpage>1590</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">11094128</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.tedde.2003.1541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tedde</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nacmias</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciantelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forleo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cellini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagnoli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caffarra</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghidoni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paganini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bracco</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorbi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Identification of new presenilin gene mutations in early-onset familial Alzheimer disease.</article-title>
                <source>Arch Neurol.</source>
                <year>2003</year>
                <volume>60</volume>
                <fpage>1541</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14623725</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.thinakaran.2004.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thinakaran</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parent</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <article-title>Identification of the role of presenilins beyond Alzheimer's disease.</article-title>
                <source>Pharmacol Res.</source>
                <year>2004</year>
                <volume>50</volume>
                <fpage>411</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15304238</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.towner.2002.1038">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Towner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loewy</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <article-title>Ethics of preimplantation diagnosis for a woman destined to develop early-onset Alzheimer disease.</article-title>
                <source>JAMA</source>
                <year>2002</year>
                <volume>287</volume>
                <fpage>1038</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">11866654</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.uemura.2003.184">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uemura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitagawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohno</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzuya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kageyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chonabayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimohama</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Presenilin 1 is involved in maturation and trafficking of N-cadherin to the plasma membrane.</article-title>
                <source>J Neurosci Res.</source>
                <year>2003</year>
                <volume>74</volume>
                <fpage>184</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">14515347</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.vanbroeckhove.1995.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <article-title>Molecular genetics of Alzheimer disease: identification of genes and gene mutations.</article-title>
                <source>Eur Neurol.</source>
                <year>1995</year>
                <volume>35</volume>
                <fpage>8</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">7737252</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.verkkoniem.2000.1103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verkkoniemi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinne</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllykangas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crook</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viitanen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haltia</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Variant Alzheimer's disease with spastic paraparesis: clinical characterization.</article-title>
                <source>Neurology.</source>
                <year>2000</year>
                <volume>54</volume>
                <fpage>1103</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10720282</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.verlinsky.2002.1018">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verlinsky</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rechitsky</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verlinsky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masciangelo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lederer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuliev</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Preimplantation diagnosis for early-onset Alzheimer disease caused by V717L mutation.</article-title>
                <source>JAMA</source>
                <year>2002</year>
                <volume>287</volume>
                <fpage>1018</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">11866650</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.vlad.2008.1672">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vlad</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowall</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felson</surname>
                    <given-names>DT</given-names>
                  </name>
                </person-group>
                <article-title>Protective effects of NSAIDs on the development of Alzheimer disease.</article-title>
                <source>Neurology.</source>
                <year>2008</year>
                <volume>70</volume>
                <fpage>1672</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18458226</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.walker.2005.294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunkan</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.</article-title>
                <source>J Neurochem.</source>
                <year>2005</year>
                <volume>92</volume>
                <fpage>294</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">15663477</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.wijsman.2005.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wijsman</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daw</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <article-title>APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <year>2005</year>
                <volume>132B</volume>
                <fpage>14</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">15389756</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.wong.1997.288">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becher</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sirinathsinghji</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trumbauer</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van der Ploeg</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sisodia</surname>
                    <given-names>SS</given-names>
                  </name>
                </person-group>
                <article-title>Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm.</article-title>
                <source>Nature.</source>
                <year>1997</year>
                <volume>387</volume>
                <fpage>288</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">9153393</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.yescas.2006.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yescas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huertas-Vazquez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villarreal-Molina</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tusi&#x000e9;-Luna</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canizales-Quinteros</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families.</article-title>
                <source>Neurogenetics.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>195</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">16628450</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.yu.2010.631">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchani</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikisch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nolte</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijsman</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease.</article-title>
                <source>Arch Neurol.</source>
                <year>2010</year>
                <volume>67</volume>
                <fpage>631</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20457965</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.zekanowski.2003.991">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zekanowski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Styczy&#x00144;ska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pep&#x00142;o&#x00144;ska</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabryelewicz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Religa</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ilkowski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kijanowska-Ha&#x00142;adyna</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotapka-Minc</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikkelsen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeffer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barczak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x00141;uczywek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasiak</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chodakowska-Zebrowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gustaw</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x00141;aczkowski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sob&#x000f3;w</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ku&#x0017a;nicki</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barcikowska</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.</article-title>
                <source>Exp Neurol.</source>
                <year>2003</year>
                <volume>184</volume>
                <fpage>991</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14769392</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="alzheimer-early.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="alzheimer-early.Suggested_Reading.reflist0">
            <ref id="alzheimer-early.REF.georgehyslop.2013.1">
              <mixed-citation publication-type="book">George-Hyslop PH, Farrer LA, Goedert M. Alzheimer disease and the frontotemporal dementias: diseases with cerebral deposition of fibrillar proteins. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> 2015. New York, NY: McGraw-Hill. Chap 234.</mixed-citation>
            </ref>
            <ref id="alzheimer-early.REF.post.1997.832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Post</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binstock</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckert</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleck</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaines</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juengst</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlinsky</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miles</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaid</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Relkin</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roses</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachs</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbock</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Truschke</surname>
                    <given-names>EF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinn</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <article-title>The clinical introduction of genetic testing for Alzheimer's disease: an ethical perspective.</article-title>
                <source>JAMA</source>
                <year>1997</year>
                <volume>277</volume>
                <fpage>832</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9052715</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer-early.REF.vanbroeckho.1998.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Alzheimer's disease: identification of genes and genetic risk factors.</article-title>
                <source>Prog Brain Res.</source>
                <year>1998</year>
                <volume>117</volume>
                <fpage>315</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">9932417</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="alzheimer-early.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="alzheimer-early.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>18 October 2012 (tb) Revision: changes in biomarkers identified in individuals with mutations associated with EOFAD</p>
            </list-item>
            <list-item>
              <p>2 August 2012 (tb) Revision: additional information about <italic toggle="yes">APP</italic> mutation p.Ala673Val</p>
            </list-item>
            <list-item>
              <p>23 December 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>28 April 2009 (tb) Revision: FISH testing available clinically for duplications in <italic toggle="yes">APP</italic></p>
            </list-item>
            <list-item>
              <p>2 October 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>26 April 2007 (tb) Revision: sequence analysis for AD1 (APP mutations) clinically available</p>
            </list-item>
            <list-item>
              <p>12 February 2007 (tb) Revision: clinical testing for APP mutations no longer available</p>
            </list-item>
            <list-item>
              <p>19 September 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>15 September 2003 (tb) Revision: clinical testing for APP available</p>
            </list-item>
            <list-item>
              <p>7 August 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 June 2001 (ca) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>24 September 1999 (pb) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>Spring 1996 (tb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
